Indian Priority Pathogen List jointly developed by DBT and WHO India Office

  18 March 2021

Antimicrobial resistance (AMR) is one of the top 10 global health threat faced by the world
today and can have a major impact on the economy, society, food safety and public health.
Infections caused by antibiotic-resistant pathogens substantially amplify the burden of both
healthcare-associated and community-acquired infections. To minimize the emergence and
spread of AMR, coordinated actions are required at the global, national and sub-national
levels.

The objectives of the IPPL are to
• guide the prioritization of research on AMR, including incentives and funding;
• help align R&D priorities with Indian public health needs; and
• support India’s leadership in containment of antibiotic resistant bacteria.
The IPPL shall be useful for policy initiatives to incentivise basic science and advanced R&D by
both public funding agencies and the private sector investing in new antibiotics.

Further reading: Government of India
Author(s): Ministry of Science & Technology
Effective Surveillance   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!